Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03394885 |
| Title | Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer (AdORN) |
| Acronym | AdORN |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Duke University |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21287 | United States | Details | |
| Duke Cancer Institute | Durham | North Carolina | 27710 | United States | Details | |
| University of Virginia | Charlottesville | Virginia | 22908 | United States | Details |